Novaminsulfon Lichtenstein (Metamizole Sodium Monohydrate)

Metamizole sodium works by non‑selectively inhibiting cyclooxygenase enzymes, leading to decreased prostaglandin production. Lower prostaglandin levels reduce peripheral pain signaling and central sensitization, while also acting on the hypothalamic thermoregulatory center to lower elevated body temperature.

The appropriate dose of Novaminsulfon Lichtenstein is determined by the prescribing healthcare professional based on the individual patient's condition, severity of symptoms, age, renal and hepatic function, and other concurrent medications. Patients should follow the prescriber's instructions and not adjust the dose on their own.

Safety data for metamizole sodium in pregnancy and lactation are limited. It should only be used during pregnancy or while breastfeeding if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers must evaluate the risk‑benefit profile for each individual case.

To order Novaminsulfon Lichtenstein, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, and will request verification of trade or institutional credentials. The team then replies with pricing, availability, shipping details and any required import documentation.

Novaminsulfon Lichtenstein (metamizole) is a non‑opioid pyrazolone analgesic, offering strong analgesic and antipyretic effects without the gastrointestinal irritation typical of many NSAIDs. Unlike opioids, it does not cause respiratory depression, but it carries a risk of rare blood dyscrasias such as agranulocytosis, which must be monitored.

Novaminsulfon Lichtenstein should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid exposure to extreme temperatures or humidity.

Novaminsulfon Lichtenstein is administered orally, as directed by a qualified healthcare professional. The tablet or oral formulation should be swallowed with water, and the exact administration schedule should follow the prescriber's instructions.

The most serious risks associated with metamizole sodium include agranulocytosis, a potentially fatal reduction in white blood cells, and severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should be instructed to seek immediate medical attention if they experience signs of infection, rash, or breathing difficulties.

Novaminsulfon Lichtenstein should be avoided in individuals with known hypersensitivity to metamizole or other pyrazolones, in patients with pre‑existing severe bone‑marrow disorders, and in those with uncontrolled hepatic or renal impairment unless closely monitored. It is also contraindicated in patients receiving other pyrazolone‑containing medications.